or PE. However, PC1/3 and PC2 prefer POMC as substrate. Demonstration of selectivity of processing enProhormone substrates are required for investigazymes for prohormone substrates illustrates the imtion of the proteolytic processing of prohormones portance of expressing recombinant prohormones and proproteins into active peptide hormones and for in vitro processing studies. ᭧ 1997 Academic Press neurotransmitters. However, the lack of prohormone proteins has been a limiting factor in elucidating proteolytic mechanisms for conversion of prohormones into active peptides. Therefore, in this
mone substrates have not been available for studies of at 5-and 3-ends of the DNAs. PCR reactions (according prohormone processing. We therefore demonstrate in the protocol of the Perkin-Elmer PCR kit) were perthis study that high-level expression of proenkephalin, formed with 1 ng cDNA as template, primers at 0.2 or pro-NPY, and POMC prohormones is achieved in Esch-0.1 mM, and 30 cycles of 1 min each at 94, 50, and 72ЊC. erichia coli using the pET3c T7 expression vector (23) . The PCR reaction for POMC included 10% glycerol. The These studies also illustrate expression of b-protachyk-pro-NPY (227 bp) and POMC (748 bp) DNAs generated inin as fusions with the maltose-binding protein and by PCR were digested with NdeI and BamHI, ligated glutathione S-transferase, using the pMAL-c (24) and (with T4 ligase) to the pET3c vector digested with NdeI pGEX-2T (25) vectors, respectively. Comparison of the and BamHI, and transformed into DH5a E. coli cells for efficiencies of bacterial expression of these prohor-amplification of plasmid constructs. mones indicates some differences in their levels of ex-
The b-PT/pET3c expression construct was generpression. Importantly, use of purified recombinant pro-ated from the human b-preprotachykinin cDNA (11). hormones for in vitro processing assays suggests selec-The 854-bp AvaII/SmaI b-PPT DNA fragment was tivity of processing enzymes for different precursor ligated to BamHI linkers, and digested with BamHI substrates. Overall, this study demonstrates that ex-to form an AvaII/BamHI DNA fragment. The AvaII/ pression of recombinant prohormones can provide BamHI fragment was ligated to the NdeI/AvaII 40-model prohormone substrates for investigations of pro-bp fragment corresponding to the 5-region of b-PT. cessing proteases.
This 40-bp fragment was generated by annealing kinased (by T4 polynucleotide kinase) oligos 5-TAT-GGAAGAAATAGGAGCCAATGATGATCTGAATTA-
MATERIALS AND METHODS
CTG-3 and 5-GACCAGTAATTCAGATCATCATTGProhormone expression constructs in the pET3c vec-GCTCCTATTTCTTCCA-3 . Ligation of the 40-bp tor. The pET3c expression vector was used to gener-NdeI/AvaII 5-fragment of b-PT, the AvaII/BamHI ate recombinant prohormones in BL21(DE3) E. coli fragment, and the NdeI/BamHI-digested pET3c veccells that contain the RNA polymerase of bacteriophage tor generated the b-PT/pET3c construct. The b-PT/ T7 (23) . The proenkephalin/pET3c construct was gen-pET3c construct was amplified in DH5a E. coli cells. erated by linearizing the rat preproenkephalin (PPE) b-Protachykinin expression constructs in pMAL-c cDNA (4) in the pSP65 vector with SmaI, followed by and pGEX-2T expression vectors. Production of b-PT/ ligation (with T4 DNA ligase) with BamHI linkers and pMAL-c and b-PT/pGEX-2T constructs for expression digestion with BamHI, and digestion with HpaII to of fusions with the maltose-binding protein (MBP) and generate a 0.72-kb proenkephalin (PE) HpaII/BamHI glutathione S-transferase (GST), respectively, was also DNA fragment. The PE HpaII/BamHI fragment was generated. The pMAL-c vector (New England Biolabs, ligated to a 51-bp synthetic DNA fragment encoding Beverly, MA) encodes a factor Xa proteolytic cleavage the 5-region of PE. This 51-bp fragment was generated site at the junction of the MBP and b-PT segments by annealing two complementary oligonucleotides (kiof the fusion protein. The pGEX-2T vector contains a nased by T4 polynucleotide kinase) to generate a 51-bp thrombin proteolytic cleavage site at the junction of NdeI/HpaII DNA fragment; annealed oligonucleotides GST and b-PT of the fusion protein. were 5-TATGGACTGCAGCCAGGACTGCGCTAAATThe b-PT/pMAL-c construct was prepared by first GCAGCTACCGCCTGGTACGTGG-3 and 5-CGGGAligating a 35-bp StuI/AvaII DNA fragment corre-CGTACCAGGCGGTAGCTGCATTTAGCGCAGTCCTsponding to the 5-region of b-PT with the 850-bp GGCTGCAGTCCA-3. Ligation of the 51-bp NdeI/ AvaII/HindIII DNA fragment of the human b-PPT HpaII 5-region of PE, the 0.72-kb HpaII/BamHI PE cDNA (11); the 35-bp StuI/AvaII fragment was fragment, and the NdeI/BamHI-digested pET3c vector formed by annealing kinased (by T4 polynucleotide generated the PE/pET3c expression construct, which kinase) oligos 5-GAAGAAATAGGAGCCAATGATwas then amplified in DH5a E. coli cells.
GATCTGAATTACTG-3 and 5-GACCAGTAATTCPro-NPY and POMC expression constructs in the AGATCATCATTGGCTCCTATTTCTTC-3 . The repET3c vector were generated by PCR (polymerase chain sultant b-PT DNA fragment was then ligated to the reaction) of rat pre-pro-NPY cDNA (6) and porcine prepMAL-c vector (New England Biolabs) that was di-POMC cDNA (7), respectively, with deletion of the NH 2 -gested with StuI and HindIII to generate the b-PT/ terminal signal sequence. Primers for PCR of pro-NPY pMAL-c construct that was expressed in PR722 E. S-prohormones. BL21(DE3) cells were incubated without and with EcoRI sites at 5-and 3-ends of b-PT, respectively. The IPTG (0.5 mM) for 0-2 h, and 1-ml aliquots were incu-PCR reaction was performed according to the protocol by bated with 35 S-methionine at 10 mCi/ml medium ( 35 SPerkin-Elmer with 1 ng b-PPT cDNA as template (linearmethionine was 800-1000 Ci/mmol, New England Nuized with HindIII), 0.5 mM of sense and antisense primers, clear) for 1 min at 37ЊC. Cells were immediately placed and thermocycling consisting of 30 cycles each at 95ЊC for on ice and 100 ml ice-cold 100% TCA (trichloroacetic 1 min, 61ЊC for 2 min, and 72ЊC for 2 min. The PCRacid) was added with vortexing, and after 30 min at generated 350-bp b-PT DNA was digested with BamHI 4ЊC the sample was centrifuged at 15,000g (at 4ЊC) to and EcoRI and ligated with the pGEX-2T vector digested collect 35 S-prohormones as the precipitate. The precipiwith the same restriction enzymes to generate the b-PT/ tate was resuspended in 50 ml 21 sample buffer (as pGEX-2T construct. The construct was amplified and exdescribed previously (16, 18) ) for SDS-PAGE gels pressed in JM101 E. coli cells (Stratagene, La Jolla, CA).
(same total cpm for each sample was loaded onto gel) All prohormone inserts in expression constructs were and autoradiography. It is noted that in uninduced subjected to DNA sequencing by the dideoxy chain tercells, basal levels of E. coli proteins were being syntheminating method with the automated DNA sequencer sized that were detected as minor 35 S-bands on SDS-(Applied Biosystems), as we have described previously PAGE gels. However, upon induction, the prohormones (26), to confirm that authentic prohormone DNA sebecame the primary proteins produced, as indicated by quences were subcloned into expression vectors.
the major bands of 35 S-prohormones on SDS-PAGE. b-PPT generated by in vitro transcription with T7 RNA induction in BL21(DE3) E. coli in M9ZB medium with polymerase and in vitro translation with wheat germ 100 mg/ml ampicillin. Expression of b-PT in the pMALextract (as described previously (16, 30) ) was digested c vector was achieved in PR722 E. coli grown in LB with hen oviduct signal peptidase (31) to assess the broth with 100 mg/ml ampicillin, and expression of bapparently slower electrophoretic mobility of
Induction of prohormone expression and analysis by
(signal peptide removed) compared to 35 S-b-PPT.
35
Smedium containing 100 mg/ml ampicillin.
b-PPT (55,000 cpm, based on trichloroacetic acid preFor expression of all prohormones, cells at an opticipitation of the precursor (16,31)) from the translation cal density of 0.15 -0.20 at 600 nm were induced by reaction was incubated with hen oviduct signal peptiaddition of IPTG (0.5 mM final concentration) to the dase (3 ml) in 0.20 M sucrose, 68 mM DTT, and 6.8 mg/ culture medium and incubation at 37ЊC for 1 -2 h. ml phosphatidylcholine, in low salt buffer consisting of At different incubation times with IPTG, 1 ml of 50 mM triethanolamine-HCl, pH 7.5, 50 mM KCl, and control (no IPTG) and IPTG-induced cell cultures 5 mM MgCl 2 at 24ЊC for 90 min. Samples were analyzed were collected by centrifugation (15,000g for 20 min by SDS-PAGE gels and autoradiography. at 4ЊC), and resuspended in 100 ml of SDS -PAGE sample buffer (16, 22) per 1-ml cell aliquot of 0.4 opPurified recombinant prohormones for in vitro protical density at 600 nm. Samples (20 ml) were ana-cessing assays by the processing enzymes PTP, 70-kDa lyzed on SDS -PAGE gels (12% polyacrylamide) and aspartyl protease, and PC1/3 and PC2. Relative rates Western blots with antibodies specific for each pro-of processing by established processing enzymes (1-3) hormone. Antibodies used in Western blots were the were assessed with purified PE, pro-NPY, and POMC. PE-18 monoclonal antibody (27) (1:1000 final dilu-As described previously (22, 29, 32) , PE, pro-NPY, and tion) to detect proenkephalin, anti-NPY serum (Ac-POMC were purified from 5-to 10-liter cultures of E. curate Chemicals, Westbury, NY) to detect pro-NPY, coli. The prohormone processing enzymes PTP, 70-kDa anti-ACTH serum (National Pituitary Agency, aspartyl protease, and PC1/3 and PC2 were purified Gaithersburg, MD) for detection of POMC, and an from bovine adrenal medullary chromaffin granules as anti-b-PT serum (28) known as PM-3 to detect ex-previously described (16, 21, 33) . pression of b-PT. For expression of b-PT as fusion
To compare relative rates of in vitro processing of proteins with the maltose-binding protein (MBP) recombinant prohormones by four different processing and glutathione S-transferase (GST), anti-MBP enzymes, prohormones at 10 05 M were incubated (in a (New England Biolabs) and anti-GST (Pharmacia, total volume of 20 ml) with purified PTP (1 ng), 70-kDa Piscataway, NJ) sera were also used to detect fusion aspartic protease (1 mg), or PC1/3 or PC2 (1 mg) under proteins. Western blots were performed as we have optimum assay conditions previously established for previously described (22, 29) . each protease (16, 21, 33) . These in vitro processing assays were conducted near estimated in vivo levels of Biosynthesis of prohormones was analyzed by incor- (Fig. 3) and pro-NPY (Fig. 4) (Fig. 3a) and 8-kDa pro-NPY (Fig. 4a) , deactive neuropeptide Y, and a COOH-terminal peptide (CTP). POMC tected by Coomassie blue protein staining of SDScontains the hormone ACTH (adrenocorticotropin hormone), the opioid peptide b-endorphin, g-MSH (g-melanocyte stimulating hor-PAGE gels. The 35-kDa band was confirmed as PE by mone), a segment known as the joining peptide (JP), and several recognition of this band in Western blots by anti-PE other peptide products (19, 20) . b-Protachykinin contains the tachyki-monoclonal antibody directed against the midregion of nin neuropeptides substance P (SP) and substance K (SK). Active the proenkephalin molecule (Fig. 3b) . Western blots peptides within prohormone molecules are typically flanked by basic with anti-NPY serum also illustrated induction of 8-residues Arg (R) or Lys (K). kDa pro-NPY (Fig. 4b) . Biosynthesis of PE and pro-NPY was confirmed by IPTG-induced incorporation of 35 S-methionine into 35-kDa PE and 8-kDa pro-NPY prohormones (34) to provide information on relative (Figs. 3c and 4c) . Based on the Coomassie blue-stained rates of prohormone processing that may occur in vivo. In addition, the amount of processing proteases used in these in vitro assays was chosen to achieve partial cleavage of each prohormone within 1-8 h incubation at 37ЊC. In vitro assays were subjected to SDS-PAGE and the initial cleavage of prohormones was quantitated by densitometry of prohormone bands. Duplicate assays varied by less than 10-15%.
RESULTS

Expression of prohormones in the pET3c vector.
Complementary DNAs encoding the prohormones (illustrated in Fig. 1 ) proenkephalin (PE) (5,6), pro-neuropeptide Y (pro-NPY) (6), proopiomelanocortin (POMC) (7,8), and b-protachykinin (b-PT) (9-11) were subcloned into NdeI and BamHI sites, downstream of the T7 promoter, of the pET3c expression vector (Fig. 2) (Fig. 5a) . The biosyntheremained, indicating that 35 S-b-PT was somewhat unsis of POMC was also demonstrated by IPTG induction stable or was partially degraded. The observation that of 35 S-methionine labeling of the 35-kDa POMC band b-PT was not detected in Western blots or by Coomas- (Fig. 5b) . Levels of POMC expression were lower than sie blue protein staining of SDS-PAGE gels (data not shown) also indicated a lower level of b-PT expression compared to the other prohormones expressed in this study. It was noted that the 16-kDa 35 S-b-protachykinin (Fig. 6a) contrasts with the apparent molecular weight of 35 S-b-preprotachykinin (generated by in vitro translation (30)) of 14 kDa that includes the NH 2 -terminal signal peptide. Removal of the signal peptidase from 14-kDa (Fig. 6b) . Thus, signal peptidase cleavage of the signal peptide of b-PPT results in b-PT with retarded mobility on SDS-PAGE. These data suggest that differences in protein conformation of b-PPT compared to b-PT may be involved in the apparently slower mobility of b-PT on SDS-PAGE. protein with MBP or with GST using the pMAL-mones were readily detected by Coomassie protein staining of SDS -PAGE gels. Moderate levels of c and pGEX-2T vectors, respectively (Fig. 7) , was excellent. Expression of the MBP/b-PT fusion was POMC were expressed, since it was detected by Western blots, but not by protein staining of gels. Expresdemonstrated by IPTG induction of a 56-kDa band that was recognized by Coomassie blue staining of sion of b-PT was lowest since it was detected by only a SDS -PAGE gel, and by anti-b-PT and by anti-MBP sera in Western blots (Fig. 7a) . The apparent the most sensitive 35 S-Met-prohormone labeling approach. Overall, most prohormones examined showed excellent expression with the pET3c vector, or with the pMAL-c and pGEX-2T vectors.
FIG. 3. Proenkephalin (PE) expression. (a) SDS-PAGE. PE expres-(23). Expression was induced in the host
Relative rates of prohormone processing by multiple processing proteases: Demonstration of precursor selectivity of processing enzymes. While it is known that the established prohormone processing enzymes-PTP (16) (17) (18) , 70-kDa aspartyl protease (19) (20) (21) (22) , and prohormone convertase (PC) enzymes (12-15,33)-possess similar cleavage specificity at paired basic residue sites (Lys-Arg, Arg-Lys, Arg-Arg, and Lys-Lys), it is not known whether each processing protease possesses preference for particular prohormones. It is predicted that these proteases may possess selectivity for prohormone substrates, since each prohormone possesses a unique protein structure defined by its primary sequence.
Comparison of the relative rates of PE, pro-NPY, and POMC in vitro processing by the established prohormone cleaving proteases PTP, 70-kDa aspartyl protease, PC1/3, and PC2 demonstrated clear differences in the relative efficiencies of these proteases to cleave the different precursors (Fig. 8) . Recombinant prohormones were purified after expression for in vitro processing by purified prohormone processing enzymes. PE and pro-NPY were most readily cleaved by PTP, with little processing by the 70-kDa aspartyl protease or PC1/3 and PC2 enzymes. In contrast, POMC was most readily processed by the 70-kDa aspartyl protease, with some processing evident with PC1/3 and PC2; however, almost no processing of POMC was detected with the PTP enzyme. It is of interest to note that PTP appears as the most efficient processing enzyme with respect to the low levels of enzyme (nanograms) needed for in vitro processing compared to the subtilisin and aspartyl proteases tested (using microgram amounts of enzyme in the assays). Overall, these studies indicate the significant property of selectivity of prohormone processing enzymes for different precursor substrates. onstrate selectivity of processing enzymes for prohor-the National Institutes of Health, Bethesda, MD). In addition, kind mone substrates.
gifts of monoclonal antibody against PE (PE-18) from Dr. Barbara Characterization of prohormones expressed in E. coli Spruce (Imperial College of Science, UK) and anti-protachykinin serum from Dr. James Krause (Washington University, St. Louis, MO) showed that expression of recombinant proenkephalin, are acknowledged. The authors thank Steve White for technical aspro-NPY, and POMC prohormones was achieved with sistance in DNA sequencing. This work was supported by grants from the pET3c vector containing the T7 promoter (23) . the National Institute of Neurological Disease and Stroke (NINDS) of These results demonstrate the effectiveness of the the National Institutes of Health (NIH), the National Institute of pET3c vector for generating recombinant prohormones. Drug Abuse (NIDA, NIH), and the National Science Foundation. Expression may also be achieved with the pMAL-c and pGEX-2T expression vectors that generate fusion pro-REFERENCES teins with MBP (24) and with GST (25) , as demon-
